Comment: Using joinpoint analysis, Coory and Bade have identified a significant trend towards lower mortality rates from prostate cancer since 1994, and relate this chronologically to the increased use of prostate-specific antigen (PSA) testing in Australia. The authors raise three reasonable questions regarding this finding:
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW.
Correspondence: michael_coory@health.qld.gov.au
Online responses are no longer available. Please refer to our instructions for authors page for more information.